These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 26861454)

  • 61. Memory T Cells Expressing an NKG2D-CAR Efficiently Target Osteosarcoma Cells.
    Fernández L; Metais JY; Escudero A; Vela M; Valentín J; Vallcorba I; Leivas A; Torres J; Valeri A; Patiño-García A; Martínez J; Leung W; Pérez-Martínez A
    Clin Cancer Res; 2017 Oct; 23(19):5824-5835. PubMed ID: 28659311
    [No Abstract]   [Full Text] [Related]  

  • 62. Prostate cancer stem-like cells/cancer-initiating cells have an autocrine system of hepatocyte growth factor.
    Nishida S; Hirohashi Y; Torigoe T; Inoue R; Kitamura H; Tanaka T; Takahashi A; Asanuma H; Masumori N; Tsukamoto T; Sato N
    Cancer Sci; 2013 Apr; 104(4):431-6. PubMed ID: 23320511
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The Antigen ASB4 on Cancer Stem Cells Serves as a Target for CTL Immunotherapy of Colorectal Cancer.
    Miyamoto S; Kochin V; Kanaseki T; Hongo A; Tokita S; Kikuchi Y; Takaya A; Hirohashi Y; Tsukahara T; Terui T; Ishitani K; Hata F; Takemasa I; Miyazaki A; Hiratsuka H; Sato N; Torigoe T
    Cancer Immunol Res; 2018 Mar; 6(3):358-369. PubMed ID: 29371260
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Aldehyde dehydrogenase-expressing colon stem cells contribute to tumorigenesis in the transition from colitis to cancer.
    Carpentino JE; Hynes MJ; Appelman HD; Zheng T; Steindler DA; Scott EW; Huang EH
    Cancer Res; 2009 Oct; 69(20):8208-15. PubMed ID: 19808966
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Clonal analysis revealed functional heterogeneity in cancer stem-like cell phenotypes in uterine endometrioid adenocarcinoma.
    Tabuchi Y; Hirohashi Y; Hashimoto S; Mariya T; Asano T; Ikeo K; Kuroda T; Mizuuchi M; Murai A; Uno S; Kawai N; Kubo T; Nakatsugawa M; Kanaseki T; Tsukahara T; Saito T; Torigoe T
    Exp Mol Pathol; 2019 Feb; 106():78-88. PubMed ID: 30503404
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Targeting the cancer initiating cell: the ultimate target for cancer therapy.
    McCubrey JA; Steelman LS; Abrams SL; Misaghian N; Chappell WH; Basecke J; Nicoletti F; Libra M; Ligresti G; Stivala F; Maksimovic-Ivanic D; Mijatovic S; Montalto G; Cervello M; Laidler P; Bonati A; Evangelisti C; Cocco L; Martelli AM
    Curr Pharm Des; 2012; 18(13):1784-95. PubMed ID: 22394167
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Vaccination with human pluripotent stem cells generates a broad spectrum of immunological and clinical responses against colon cancer.
    Li Y; Zeng H; Xu RH; Liu B; Li Z
    Stem Cells; 2009 Dec; 27(12):3103-11. PubMed ID: 19816950
    [TBL] [Abstract][Full Text] [Related]  

  • 68. A novel BMI-1 inhibitor QW24 for the treatment of stem-like colorectal cancer.
    Wang J; Xing Y; Wang Y; He Y; Wang L; Peng S; Yang L; Xie J; Li X; Qiu W; Yi Z; Liu M
    J Exp Clin Cancer Res; 2019 Oct; 38(1):422. PubMed ID: 31640758
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Self-renewal as a therapeutic target in human colorectal cancer.
    Kreso A; van Galen P; Pedley NM; Lima-Fernandes E; Frelin C; Davis T; Cao L; Baiazitov R; Du W; Sydorenko N; Moon YC; Gibson L; Wang Y; Leung C; Iscove NN; Arrowsmith CH; Szentgyorgyi E; Gallinger S; Dick JE; O'Brien CA
    Nat Med; 2014 Jan; 20(1):29-36. PubMed ID: 24292392
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Heterotypic cell-in-cell structures in colon cancer can be regulated by IL-6 and lead to tumor immune escape.
    Wang S; Li L; Zhou Y; He Y; Wei Y; Tao A
    Exp Cell Res; 2019 Sep; 382(1):111447. PubMed ID: 31150612
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Active specific immunotherapy of murine colon adenocarcinoma with recombinant vaccinia/interleukin-2-infected tumor cell vaccines.
    Bash JA
    Ann N Y Acad Sci; 1993 Aug; 690():331-3. PubMed ID: 8368746
    [No Abstract]   [Full Text] [Related]  

  • 72. Significant clinical response of advanced colon cancer to peptide vaccine therapy: a case report.
    Yasuda S; Tsuchiya I; Okada K; Tanaka A; Suzuki T; Sadahiro S; Takeda K; Yamamoto S; Nakui M
    Tokai J Exp Clin Med; 2012 Jul; 37(2):57-61. PubMed ID: 22763829
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Differential remodeling of extracellular matrices by breast cancer initiating cells.
    Raja AM; Xu S; Zhuo S; Tai DC; Sun W; So PT; Welsch RE; Chen CS; Yu H
    J Biophotonics; 2015 Oct; 8(10):804-15. PubMed ID: 25597396
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Generating the Abscopal Effect by Combining Proapoptotic Peptides With IL-12-Based Immunotherapy.
    Martins F; Stalder G; Obeid M
    Neoplasia; 2018 Feb; 20(2):193-196. PubMed ID: 29287248
    [No Abstract]   [Full Text] [Related]  

  • 75. Multi-OMICs data analysis identifies molecular features correlating with tumor immunity in colon cancer.
    Elsayed I; Elsayed N; Feng Q; Sheahan K; Moran B; Wang X
    Cancer Biomark; 2022; 33(2):261-271. PubMed ID: 35213358
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Tumor malignancy by genetic transfer between cells forming cell-in-cell structures.
    Wang R; Zhong H; Wang C; Huang X; Huang A; Du N; Wang D; Sun Q; He M
    Cell Death Dis; 2023 Mar; 14(3):195. PubMed ID: 36914619
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Development of MGD007, a gpA33 x CD3-Bispecific DART Protein for T-Cell Immunotherapy of Metastatic Colorectal Cancer.
    Moore PA; Shah K; Yang Y; Alderson R; Roberts P; Long V; Liu D; Li JC; Burke S; Ciccarone V; Li H; Fieger CB; Hooley J; Easton A; Licea M; Gorlatov S; King KL; Young P; Adami A; Loo D; Chichili GR; Liu L; Smith DH; Brown JG; Chen FZ; Koenig S; Mather J; Bonvini E; Johnson S
    Mol Cancer Ther; 2018 Aug; 17(8):1761-1772. PubMed ID: 29866746
    [TBL] [Abstract][Full Text] [Related]  

  • 78. A rapid in vitro methodology for simultaneous target discovery and antibody generation against functional cell subpopulations.
    Nixon AML; Duque A; Yelle N; McLaughlin M; Davoudi S; Pedley NM; Haynes J; Brown KR; Pan J; Hart T; Gilbert PM; Singh SK; O'Brien CA; Sidhu SS; Moffat J
    Sci Rep; 2019 Jan; 9(1):842. PubMed ID: 30696911
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Human prostate cancer initiating cells isolated directly from localized cancer do not form prostaspheres in primary culture.
    Chen S; Principessa L; Isaacs JT
    Prostate; 2012 Sep; 72(13):1478-89. PubMed ID: 22396312
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The Cross Talk between Cancer Stem Cells/Cancer Initiating Cells and Tumor Microenvironment: The Missing Piece of the Puzzle for the Efficient Targeting of these Cells with Immunotherapy.
    Ravindran S; Rasool S; Maccalli C
    Cancer Microenviron; 2019 Dec; 12(2-3):133-148. PubMed ID: 31758404
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.